Jason Daniel Goodson
EVP & Head of Corp Development, Keenova Therapeutics plc.
Companies
- Keenova Therapeutics plcEVP & Head of Corp Development Aug 26, 2022 to Jan 2, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Keenova Therapeutics plc3,750 shares2Jan 1, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 1, 2025Shares withheld for tax 1,720 shares of Keenova Therapeutics plc2
- Jan 1, 2025Exercised options 5,470 shares of Keenova Therapeutics plc2
- Nov 14, 2023Returned to company 33,133 shares of Keenova Therapeutics plc3
- Aug 17, 2023Shares withheld for tax 5,545 shares at $0.69 of Keenova Therapeutics plc4
- Mar 16, 2023Bought 933 shares at $8.39 of Keenova Therapeutics plc5
- Mar 16, 2023Bought 200 shares at $8.35 of Keenova Therapeutics plc5
- Dec 14, 2022Granted 37,545 shares of Keenova Therapeutics plc6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Nov 16, 2023
- 4SEC EDGARForm 4 filed Aug 18, 2023
- 5SEC EDGARForm 4 filed Mar 17, 2023
- 6SEC EDGARForm 4 filed Dec 22, 2022